Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.58 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.51 |
| ▸ | PLA2G2C | Q5R387 | 3/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23016732 | 0.91 | USP2 (0.57) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL10664178 | 0.91 | USP2 (0.57) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL17528452 | 0.91 | USP2 (0.57) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL28659331 | 0.91 | USP2 (0.57) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL30888163 | 0.91 | USP2 (0.57) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL31347426 | 0.90 | LPAR5 (0.73) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL31347422 | 0.90 | LPAR5 (0.73) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL31347452 | 0.90 | LPAR5 (0.73) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL31347419 | 0.90 | LPAR5 (0.73) | USP2LPAR5P2RY10PLA2G2CLPAR3 | |
| SCHEMBL31347436 | 0.90 | LPAR5 (0.73) | USP2LPAR5P2RY10PLA2G2CLPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180064813-A1 | Oral Composition for Delivery of Drugs and Other Substances | AVANTI POLAR LIPIDS, LLC | 2018-03-08 | — | — | US | disclosed |
| US-9872908-B2 | Oral composition for delivery of drugs and other substances | AVANTI POLAR LIPIDS, INC. (US) | 2018-01-23 | — | — | US | disclosed |
| US-20160166699-A1 | Oral Composition for Delivery of Drugs and Other Substances | AVANTI POLAR LIPIDS, LLC | 2016-06-16 | — | — | US | disclosed |
| WO-2016025401-A1 | ORAL COMPOSITION FOR DELIVERY OF DRUGS AND OTHER SUBSTANCES | AVANTI POLAR LIPIDS, INC. (US) | 2016-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166699-A1 | Oral Composition for Delivery of Drugs and Other Substances | MGLL, SGMS2, LIPA | USP2 3558/4885LPAR5 68/4885P2RY10 397/4885 |
| US-20180064813-A1 | Oral Composition for Delivery of Drugs and Other Substances | MGLL, SGMS2, LIPA | USP2 3558/4885LPAR5 68/4885P2RY10 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.